Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.

April 24, 2025. More for You ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

In this edition of Daily Dose, Dr. Lacy Anderson answers a viewer's question about what discounts are available for weight ...

You’ll use a new pen each time you take a dose. You (or a caregiver) will need to inject Ozempic or Wegovy under the skin of your abdomen, thigh, or upper arm. Your doctor or other healthcare ...

Fact checked by Nick Blackmer Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but ...

The FDA has issued a warning about counterfeit Ozempic injections circulating in the U.S., urging consumers to check labels ...

Eli Lilly Takes on Novo Nordisk with Orforglipron, an Oral Drug for Diabetes and Obesity That Could Change the Market. FDA ...

🇺🇸 FAKE OZEMPIC ALERT: FDA SAYS DOUBLE-CHECK YOUR PEN BEFORE YOU INJECT The FDA just ... When Ozempic and Wegovy experienced a shortage in February 2025, the FDA announced the shortage ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...